Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Colon Cancer Screening: later-stage trial registry

1 of 5 indexed Colon Cancer Screening trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 1 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Colon Cancer Screening: 5 US clinical trials tracked, 1 recruiting.

Colon Cancer Screening is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Emily Rosenzweig, running 1 of these trials.

Enrollment posture brief

Registry condition colon-cancer-screening

OPEN 1 | RECR 20% | LATE 1 | EARLY 0 | RANK #3391 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Colon Cancer Screening (this)20%
Open-enrollment share among volume-matched conditions near Colon Cancer Screening

Colon Cancer Screening lists 1 open slots (20% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Colon Cancer Screening on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Colon Cancer Screening is recruiting below its size-band peers.

    1 of 5 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Colon Cancer Screening research.

    Emily Rosenzweig accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Most Colon Cancer Screening trials plan to enrol fewer than 100 people.

    Median target enrolment is 80 among the 5 trials that report a genuine target (sentinel values excluded). 3 of those (60%) plan for fewer than 100 participants.

  4. Colon Cancer Screening research is mostly interventional.

    5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Named interventions

Most-linked intervention names on Colon Cancer Screening records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Medivators Endocuff Device
1 trials
Olympus transparent cap Device
1 trials
Three Messaging Nudges Behavioral
1 trials
eGuide to Colonoscopy and in office ipad education Other
1 trials
Colorectal Cancer (CRC) education alone Other
1 trials
FITx3 intervention and CRC education Other
1 trials
SUPRPEP Drug
1 trials
Golytely Drug
1 trials

US sites by state

Facility locations filed on Colon Cancer Screening trials. A trial with sites in several states counts in each.

New York 1 trials
New Jersey 1 trials
Missouri 1 trials
Maryland 1 trials
Georgia 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Colon Cancer Screening page

5 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Colon Cancer Screening trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Emily Rosenzweig sponsors the most Colon Cancer Screening trials on record, review their full trial history before evaluating a specific study. See Emily Rosenzweig's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Colon Cancer Screening condition card totals 5 registered trials; most-linked intervention Medivators Endocuff; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.